nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—GABRB2—Topiramate—migraine	0.258	0.395	CbGbCtD
Etomidate—GABRG2—Topiramate—migraine	0.216	0.33	CbGbCtD
Etomidate—GABRA1—Topiramate—migraine	0.179	0.275	CbGbCtD
Etomidate—Snoring—Gabapentin—migraine	0.0191	0.14	CcSEcCtD
Etomidate—SLC2A1—blood vessel—migraine	0.0105	0.144	CbGeAlD
Etomidate—SLC2A1—neck—migraine	0.00753	0.103	CbGeAlD
Etomidate—Hypoventilation—Gabapentin—migraine	0.00742	0.0544	CcSEcCtD
Etomidate—Laryngospasm—Propranolol—migraine	0.00685	0.0502	CcSEcCtD
Etomidate—SLC2A1—Regulation of insulin secretion—CACNA1A—migraine	0.00656	0.0495	CbGpPWpGaD
Etomidate—Laryngospasm—Verapamil—migraine	0.0063	0.0462	CcSEcCtD
Etomidate—GABRB2—Ligand-gated ion channel transport—HTR3A—migraine	0.00592	0.0446	CbGpPWpGaD
Etomidate—SLC2A1—brainstem—migraine	0.00575	0.0787	CbGeAlD
Etomidate—CYP11B2—ACE Inhibitor Pathway—ACE—migraine	0.0057	0.043	CbGpPWpGaD
Etomidate—GABRG2—Ligand-gated ion channel transport—HTR3A—migraine	0.00541	0.0408	CbGpPWpGaD
Etomidate—SLC2A1—Integration of energy metabolism—CACNA1A—migraine	0.00516	0.0389	CbGpPWpGaD
Etomidate—Respiratory failure—Verapamil—migraine	0.00479	0.0351	CcSEcCtD
Etomidate—GABRA1—Ligand-gated ion channel transport—HTR3A—migraine	0.00473	0.0357	CbGpPWpGaD
Etomidate—SLC2A1—cardiovascular system—migraine	0.0047	0.0642	CbGeAlD
Etomidate—Myoclonus—Gabapentin—migraine	0.0046	0.0337	CcSEcCtD
Etomidate—Hypoxia—Gabapentin—migraine	0.00435	0.0319	CcSEcCtD
Etomidate—CYP11B2—cardiovascular system—migraine	0.00402	0.055	CbGeAlD
Etomidate—Hyperventilation—Gabapentin—migraine	0.00402	0.0294	CcSEcCtD
Etomidate—Laryngospasm—Timolol—migraine	0.00398	0.0291	CcSEcCtD
Etomidate—Hiccups—Valproic Acid—migraine	0.00334	0.0244	CcSEcCtD
Etomidate—Apnoea—Gabapentin—migraine	0.00326	0.0239	CcSEcCtD
Etomidate—SLC2A1—head—migraine	0.00318	0.0435	CbGeAlD
Etomidate—Respiratory failure—Timolol—migraine	0.00302	0.0222	CcSEcCtD
Etomidate—SLC2A1—nervous system—migraine	0.00301	0.0412	CbGeAlD
Etomidate—SLC2A1—central nervous system—migraine	0.0029	0.0397	CbGeAlD
Etomidate—ADRA2B—Monoamine GPCRs—HTR1D—migraine	0.00286	0.0216	CbGpPWpGaD
Etomidate—SLC2A1—cerebellum—migraine	0.00284	0.0388	CbGeAlD
Etomidate—Arrhythmia—Amitriptyline—migraine	0.00282	0.0206	CcSEcCtD
Etomidate—Respiratory failure—Gabapentin—migraine	0.00282	0.0206	CcSEcCtD
Etomidate—Hiccups—Gabapentin—migraine	0.00277	0.0203	CcSEcCtD
Etomidate—ADRA2B—Monoamine GPCRs—HTR2B—migraine	0.00266	0.02	CbGpPWpGaD
Etomidate—Bradycardia—Propranolol—migraine	0.00261	0.0192	CcSEcCtD
Etomidate—GABRG2—trigeminal ganglion—migraine	0.00254	0.0347	CbGeAlD
Etomidate—Bradycardia—Verapamil—migraine	0.0024	0.0176	CcSEcCtD
Etomidate—ADRA2B—Amine ligand-binding receptors—HTR1D—migraine	0.0024	0.0181	CbGpPWpGaD
Etomidate—Convulsion—Amitriptyline—migraine	0.00238	0.0174	CcSEcCtD
Etomidate—Hypertension—Amitriptyline—migraine	0.00237	0.0174	CcSEcCtD
Etomidate—SLC2A1—brain—migraine	0.0023	0.0315	CbGeAlD
Etomidate—SLC2A1—Transmembrane transport of small molecules—TRPM8—migraine	0.0023	0.0173	CbGpPWpGaD
Etomidate—GABRB2—brainstem—migraine	0.00224	0.0307	CbGeAlD
Etomidate—ADRA2B—Amine ligand-binding receptors—HTR2B—migraine	0.00223	0.0168	CbGpPWpGaD
Etomidate—Tachycardia—Amitriptyline—migraine	0.00219	0.016	CcSEcCtD
Etomidate—SLC2A1—NRF2 pathway—SLC6A4—migraine	0.00212	0.016	CbGpPWpGaD
Etomidate—Pseudoephedrine—TNF—migraine	0.00211	0.379	CrCbGaD
Etomidate—Hypotension—Amitriptyline—migraine	0.00209	0.0153	CcSEcCtD
Etomidate—GABRB2—Ion channel transport—TRPM8—migraine	0.00199	0.015	CbGpPWpGaD
Etomidate—GABRA1—brainstem—migraine	0.00198	0.0271	CbGeAlD
Etomidate—SLC2A1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—migraine	0.00197	0.0149	CbGpPWpGaD
Etomidate—SLC2A1—HIF-1-alpha transcription factor network—FOS—migraine	0.00197	0.0148	CbGpPWpGaD
Etomidate—Convulsion—Propranolol—migraine	0.00194	0.0142	CcSEcCtD
Etomidate—CYP19A1—Ovarian Infertility Genes—PGR—migraine	0.00186	0.0141	CbGpPWpGaD
Etomidate—GABRG2—Ion channel transport—TRPM8—migraine	0.00182	0.0138	CbGpPWpGaD
Etomidate—Convulsion—Verapamil—migraine	0.00178	0.0131	CcSEcCtD
Etomidate—Hypertension—Verapamil—migraine	0.00178	0.013	CcSEcCtD
Etomidate—Pethidine—SLC6A4—migraine	0.00176	0.316	CrCbGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—ATP1A3—migraine	0.00174	0.0131	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—ATP1A2—migraine	0.00174	0.0131	CbGpPWpGaD
Etomidate—ADRA2B—Monoamine GPCRs—HTR1B—migraine	0.00173	0.0131	CbGpPWpGaD
Etomidate—Bradycardia—Valproic Acid—migraine	0.00171	0.0125	CcSEcCtD
Etomidate—Pseudoephedrine—SLC6A4—migraine	0.0017	0.305	CrCbGaD
Etomidate—ADRA2B—Monoamine GPCRs—HTR1A—migraine	0.00167	0.0126	CbGpPWpGaD
Etomidate—Tachycardia—Verapamil—migraine	0.00164	0.012	CcSEcCtD
Etomidate—ADRA2B—Monoamine GPCRs—HTR2C—migraine	0.00161	0.0121	CbGpPWpGaD
Etomidate—SLC2A1—NRF2 pathway—TGFBR2—migraine	0.0016	0.0121	CbGpPWpGaD
Etomidate—GABRA1—Ion channel transport—TRPM8—migraine	0.00159	0.012	CbGpPWpGaD
Etomidate—Hypotension—Verapamil—migraine	0.00157	0.0115	CcSEcCtD
Etomidate—Pain—Propranolol—migraine	0.00156	0.0114	CcSEcCtD
Etomidate—CYP19A1—FSH signaling pathway—BDNF—migraine	0.00152	0.0115	CbGpPWpGaD
Etomidate—Bradycardia—Timolol—migraine	0.00152	0.0111	CcSEcCtD
Etomidate—GABRB2—Ion channel transport—ATP1A3—migraine	0.00151	0.0114	CbGpPWpGaD
Etomidate—GABRB2—Ion channel transport—ATP1A2—migraine	0.00151	0.0114	CbGpPWpGaD
Etomidate—Arrhythmia—Valproic Acid—migraine	0.0015	0.011	CcSEcCtD
Etomidate—SLC2A1—Transmembrane transport of small molecules—HTR3A—migraine	0.00148	0.0112	CbGpPWpGaD
Etomidate—ADRA2B—Amine ligand-binding receptors—HTR1B—migraine	0.00146	0.011	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—KCNK18—migraine	0.00145	0.0109	CbGpPWpGaD
Etomidate—Pain—Verapamil—migraine	0.00144	0.0105	CcSEcCtD
Etomidate—Vomiting—Amitriptyline—migraine	0.00142	0.0104	CcSEcCtD
Etomidate—Bradycardia—Gabapentin—migraine	0.00141	0.0104	CcSEcCtD
Etomidate—ADRA2B—Monoamine GPCRs—HTR7—migraine	0.00141	0.0106	CbGpPWpGaD
Etomidate—ADRA2B—Amine ligand-binding receptors—HTR1A—migraine	0.0014	0.0106	CbGpPWpGaD
Etomidate—GABRG2—Ion channel transport—ATP1A3—migraine	0.00138	0.0104	CbGpPWpGaD
Etomidate—GABRG2—Ion channel transport—ATP1A2—migraine	0.00138	0.0104	CbGpPWpGaD
Etomidate—ADRA2B—Amine ligand-binding receptors—HTR2C—migraine	0.00135	0.0102	CbGpPWpGaD
Etomidate—Arrhythmia—Timolol—migraine	0.00133	0.00976	CcSEcCtD
Etomidate—GABRG2—Neuronal System—KCNK18—migraine	0.00132	0.00999	CbGpPWpGaD
Etomidate—GABRB2—Ion channel transport—HTR3A—migraine	0.00128	0.00969	CbGpPWpGaD
Etomidate—Hypertension—Valproic Acid—migraine	0.00126	0.00922	CcSEcCtD
Etomidate—GABRA1—SIDS Susceptibility Pathways—ATP1A3—migraine	0.00124	0.00939	CbGpPWpGaD
Etomidate—GABRB2—head—migraine	0.00124	0.017	CbGeAlD
Etomidate—GABRG2—head—migraine	0.00124	0.017	CbGeAlD
Etomidate—GABRA1—Ion channel transport—ATP1A2—migraine	0.00121	0.00911	CbGpPWpGaD
Etomidate—GABRA1—Ion channel transport—ATP1A3—migraine	0.00121	0.00911	CbGpPWpGaD
Etomidate—Bradycardia—Topiramate—migraine	0.00119	0.00871	CcSEcCtD
Etomidate—ADRA2B—Amine ligand-binding receptors—HTR7—migraine	0.00119	0.00894	CbGpPWpGaD
Etomidate—GABRB2—nervous system—migraine	0.00118	0.0161	CbGeAlD
Etomidate—GABRG2—nervous system—migraine	0.00118	0.0161	CbGeAlD
Etomidate—GABRG2—Ion channel transport—HTR3A—migraine	0.00117	0.00886	CbGpPWpGaD
Etomidate—Tachycardia—Valproic Acid—migraine	0.00116	0.00851	CcSEcCtD
Etomidate—Vomiting—Propranolol—migraine	0.00116	0.0085	CcSEcCtD
Etomidate—GABRA1—Neuronal System—KCNK18—migraine	0.00116	0.00873	CbGpPWpGaD
Etomidate—GABRG2—central nervous system—migraine	0.00113	0.0155	CbGeAlD
Etomidate—GABRB2—central nervous system—migraine	0.00113	0.0155	CbGeAlD
Etomidate—Hypertension—Timolol—migraine	0.00112	0.00821	CcSEcCtD
Etomidate—Hypotension—Valproic Acid—migraine	0.00111	0.00815	CcSEcCtD
Etomidate—GABRB2—cerebellum—migraine	0.00111	0.0151	CbGeAlD
Etomidate—GABRG2—cerebellum—migraine	0.00111	0.0151	CbGeAlD
Etomidate—GABRA1—head—migraine	0.00109	0.015	CbGeAlD
Etomidate—Vomiting—Verapamil—migraine	0.00107	0.00782	CcSEcCtD
Etomidate—GABRA1—SIDS Susceptibility Pathways—HTR3A—migraine	0.00106	0.00798	CbGpPWpGaD
Etomidate—Convulsion—Gabapentin—migraine	0.00105	0.00767	CcSEcCtD
Etomidate—Hypertension—Gabapentin—migraine	0.00104	0.00765	CcSEcCtD
Etomidate—GABRA1—nervous system—migraine	0.00104	0.0142	CbGeAlD
Etomidate—GABRA1—Ion channel transport—HTR3A—migraine	0.00103	0.00775	CbGpPWpGaD
Etomidate—Pain—Valproic Acid—migraine	0.00102	0.00746	CcSEcCtD
Etomidate—CYP19A1—head—migraine	0.00101	0.0137	CbGeAlD
Etomidate—GABRA1—central nervous system—migraine	0.000999	0.0137	CbGeAlD
Etomidate—Hypotension—Timolol—migraine	0.00099	0.00725	CcSEcCtD
Etomidate—ADRA2B—Monoamine GPCRs—HTR2A—migraine	0.000987	0.00745	CbGpPWpGaD
Etomidate—GABRA1—cerebellum—migraine	0.000977	0.0134	CbGeAlD
Etomidate—SLC2A1—Insulin Signaling—FOS—migraine	0.000969	0.00731	CbGpPWpGaD
Etomidate—Tachycardia—Gabapentin—migraine	0.000963	0.00706	CcSEcCtD
Etomidate—CYP19A1—nervous system—migraine	0.000953	0.013	CbGeAlD
Etomidate—GABRB2—Transmission across Chemical Synapses—CACNA1A—migraine	0.000923	0.00696	CbGpPWpGaD
Etomidate—Hypotension—Gabapentin—migraine	0.000922	0.00676	CcSEcCtD
Etomidate—CYP19A1—central nervous system—migraine	0.000918	0.0125	CbGeAlD
Etomidate—Pain—Timolol—migraine	0.000906	0.00664	CcSEcCtD
Etomidate—GABRB2—brain—migraine	0.000899	0.0123	CbGeAlD
Etomidate—GABRG2—brain—migraine	0.000899	0.0123	CbGeAlD
Etomidate—Convulsion—Topiramate—migraine	0.000881	0.00646	CcSEcCtD
Etomidate—Hypertension—Topiramate—migraine	0.000878	0.00643	CcSEcCtD
Etomidate—GABRG2—Transmission across Chemical Synapses—CACNA1A—migraine	0.000844	0.00637	CbGpPWpGaD
Etomidate—Pain—Gabapentin—migraine	0.000844	0.00618	CcSEcCtD
Etomidate—ADRA2B—Amine ligand-binding receptors—HTR2A—migraine	0.00083	0.00626	CbGpPWpGaD
Etomidate—Tachycardia—Topiramate—migraine	0.00081	0.00594	CcSEcCtD
Etomidate—GABRA1—brain—migraine	0.000793	0.0108	CbGeAlD
Etomidate—Hypotension—Topiramate—migraine	0.000776	0.00568	CcSEcCtD
Etomidate—Vomiting—Valproic Acid—migraine	0.000757	0.00554	CcSEcCtD
Etomidate—GABRA1—Transmission across Chemical Synapses—CACNA1A—migraine	0.000738	0.00556	CbGpPWpGaD
Etomidate—CYP19A1—brain—migraine	0.000729	0.00996	CbGeAlD
Etomidate—Pain—Topiramate—migraine	0.00071	0.0052	CcSEcCtD
Etomidate—GABRB2—Neuronal System—CACNA1A—migraine	0.000707	0.00533	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—TRPM8—migraine	0.000694	0.00523	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—FOS—migraine	0.00068	0.00513	CbGpPWpGaD
Etomidate—Vomiting—Timolol—migraine	0.000674	0.00494	CcSEcCtD
Etomidate—GABRG2—Neuronal System—CACNA1A—migraine	0.000647	0.00488	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—TRPM8—migraine	0.000634	0.00479	CbGpPWpGaD
Etomidate—Vomiting—Gabapentin—migraine	0.000627	0.0046	CcSEcCtD
Etomidate—ADRA2B—G alpha (i) signalling events—HTR1D—migraine	0.000594	0.00448	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CACNA1A—migraine	0.00059	0.00445	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—CACNA1A—migraine	0.000565	0.00426	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—TRPM8—migraine	0.000555	0.00418	CbGpPWpGaD
Etomidate—SLC2A1—Disease—LRP1—migraine	0.000553	0.00417	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000551	0.00416	CbGpPWpGaD
Etomidate—Vomiting—Topiramate—migraine	0.000528	0.00387	CcSEcCtD
Etomidate—GABRB2—Transmembrane transport of small molecules—ATP1A3—migraine	0.000526	0.00397	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—ATP1A2—migraine	0.000526	0.00397	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000513	0.00387	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—HTR1A—migraine	0.000503	0.0038	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—TAC1—migraine	0.000496	0.00374	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—RAMP1—migraine	0.000495	0.00374	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CALCRL—migraine	0.000495	0.00374	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000486	0.00367	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—ATP1A3—migraine	0.000481	0.00363	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—ATP1A2—migraine	0.000481	0.00363	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000472	0.00356	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—HTR3A—migraine	0.000447	0.00337	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000439	0.00331	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—ATP1A3—migraine	0.00042	0.00317	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—ATP1A2—migraine	0.00042	0.00317	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—HTR3A—migraine	0.000409	0.00308	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000398	0.003	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—HTR1B—migraine	0.00036	0.00272	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—HTR1D—migraine	0.00036	0.00271	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—HTR3A—migraine	0.000357	0.0027	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CALCA—migraine	0.000356	0.00269	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—BDNF—migraine	0.000353	0.00266	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—HTR1A—migraine	0.000347	0.00261	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—HTR2B—migraine	0.000334	0.00252	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000334	0.00252	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000322	0.00243	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000311	0.00234	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CACNA1A—migraine	0.000309	0.00233	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000302	0.00228	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—HTR2A—migraine	0.000298	0.00225	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—ESR1—migraine	0.000288	0.00217	CbGpPWpGaD
Etomidate—SLC2A1—Disease—TGFBR2—migraine	0.000287	0.00216	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000286	0.00216	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CALCRL—migraine	0.00028	0.00211	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—RAMP1—migraine	0.00028	0.00211	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000276	0.00208	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000272	0.00205	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000271	0.00205	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000271	0.00205	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000266	0.00201	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CACNA1A—migraine	0.000266	0.00201	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000259	0.00195	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CALCRL—migraine	0.000254	0.00192	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—RAMP1—migraine	0.000254	0.00192	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000233	0.00176	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MTHFR—migraine	0.000233	0.00176	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—HTR1B—migraine	0.000218	0.00164	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—HTR1A—migraine	0.00021	0.00158	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—TAC1—migraine	0.000207	0.00156	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—NPS—migraine	0.000207	0.00156	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR1D—migraine	0.000203	0.00153	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—HTR2C—migraine	0.000203	0.00153	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—EDNRA—migraine	0.000197	0.00149	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—MTHFR—migraine	0.000195	0.00147	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000191	0.00144	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CALCA—migraine	0.00019	0.00143	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR2B—migraine	0.000189	0.00143	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR1D—migraine	0.000185	0.00139	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—HTR7—migraine	0.000178	0.00134	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR2B—migraine	0.000172	0.00129	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000163	0.00123	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CACNA1A—migraine	0.000151	0.00114	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CALCRL—migraine	0.00015	0.00113	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RAMP1—migraine	0.00015	0.00113	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—TNF—migraine	0.000128	0.000967	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—HTR2A—migraine	0.000124	0.000938	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR1B—migraine	0.000123	0.000929	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR1A—migraine	0.000119	0.000894	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—TAC1—migraine	0.000117	0.000881	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—NPS—migraine	0.000117	0.000881	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR2C—migraine	0.000115	0.000864	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR1B—migraine	0.000112	0.000844	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—EDNRA—migraine	0.000111	0.00084	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR1D—migraine	0.000109	0.000823	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR1A—migraine	0.000108	0.000812	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CALCA—migraine	0.000107	0.000809	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—TAC1—migraine	0.000106	0.0008	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—NPS—migraine	0.000106	0.0008	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR2C—migraine	0.000104	0.000784	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—MTHFR—migraine	0.000102	0.00077	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR2B—migraine	0.000101	0.000765	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—EDNRA—migraine	0.000101	0.000763	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR7—migraine	0.0001	0.000757	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CALCA—migraine	9.74e-05	0.000735	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR7—migraine	9.11e-05	0.000687	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—LRP1—migraine	8.93e-05	0.000673	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—MTHFR—migraine	8.8e-05	0.000664	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR2A—migraine	7.03e-05	0.00053	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOTCH4—migraine	6.85e-05	0.000517	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR1B—migraine	6.61e-05	0.000498	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR2A—migraine	6.38e-05	0.000481	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR1A—migraine	6.36e-05	0.00048	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NPS—migraine	6.26e-05	0.000473	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PGR—migraine	6.26e-05	0.000473	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TAC1—migraine	6.26e-05	0.000473	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR2C—migraine	6.14e-05	0.000463	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EDNRA—migraine	5.98e-05	0.000451	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOTCH3—migraine	5.82e-05	0.000439	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CALCA—migraine	5.75e-05	0.000434	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR7—migraine	5.38e-05	0.000406	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—MTHFR—migraine	4.99e-05	0.000376	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TGFBR2—migraine	4.63e-05	0.00035	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR2A—migraine	3.77e-05	0.000284	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ESR1—migraine	3.35e-05	0.000252	CbGpPWpGaD
